Skip to main content

Research Repository

Advanced Search

Aberrant fumarate metabolism links interferon release in diffuse systemic sclerosis.

Steadman, Thomas; O'Reilly, Steven

Authors

Thomas Steadman

Steven O'Reilly



Abstract

Background
Systemic Sclerosis (SSc) is an idiopathic rheumatic inflammatory disease that is characterised by inflammation and skin fibrosis. Type I interferon is significantly elevated in the disease.
Objective
The objective of this study is to determine the role of the TCA cycle metabolite fumarate in SSc.
Methods
CD14 + cells were isolated from 12 SSc patients and healthy controls. Fumarate hydratase and Interferon dependant genes were quantified by qPCR. In vitro inhibition of STING using a small molecule STING inhibitor and enforced mitophagy was induced in vitro and IFN-β release was quantified. VDAC1 inhibitor was used to determine the role of mt DNA release in IFN-β induction. In whole skin biopsies fumarate and succinate was quantified.
Results
Fumarate Hydratase is significantly reduced in SSc monocytes. Type I interferon is also elevated in monocytes from SSc donors compared to controls. The mitochondrial-specific stress marker GDF-15 was significantly elevated in SSc monocytes. Blockade of the cGAS-STING pathway chemically reduced interferon-β release and induced mitophagy also retarded release of the cytokine in response to LPS stimulation. Inhibition of VDAC1 mitigated IFN-β, as did the depletion of mitochondria in cells. Furthermore, the itaconate derivative 4-octyl itaconate reduced IFN-β induction in SSc monocytes, that was downstream of mitochondrial nucleic acid release. Fumarate, but not succinate was elevated in whole skin biopsies.
Conclusion
Fumarate metabolism links interferon release in SSc and may underlie the aberrant expression of interferon in SSc via cytosolic DNA released from mitochondria.

Citation

Steadman, T., & O'Reilly, S. (2025). Aberrant fumarate metabolism links interferon release in diffuse systemic sclerosis. Journal of Dermatological Science, 117(2), 30-35. https://doi.org/10.1016/j.jdermsci.2025.01.002

Journal Article Type Article
Acceptance Date Jan 6, 2025
Online Publication Date Jan 8, 2025
Publication Date 2025-02
Deposit Date Feb 18, 2025
Journal Journal of Dermatological Science
Print ISSN 0923-1811
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 117
Issue 2
Pages 30-35
DOI https://doi.org/10.1016/j.jdermsci.2025.01.002
Keywords Interferon, Fumarate hydratase, Fibrosis, DNA, STING, Systemic sclerosis, CGAS
Public URL https://durham-repository.worktribe.com/output/3474611